Sopharma Properties ADSITS logo

6S6 - Sopharma Properties ADSITS Share Price

BGN5.45 -0.2  -2.7%

Last Trade - 14/09/20

Small Cap
Market Cap £56.0m
Enterprise Value £60.6m
Revenue £5.45m
Position in Universe 265th / 629
Unlock 6S6 Revenue
Relative Strength (%)
1m +0.83%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -18.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
10.1 10.3 10.1 10.6 11.2 11.6 +2.8%
+24.2 +10.7 -13.2 -2.7 +698 +3.4
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Sopharma Properties ADSITS revenues remained flat at BGN5.5M. Net income increased 2% to BGN3.6M., also reflect Other Sales decrease of 50% to BGN14K. Net income benefited from Interest Expenses decrease of 21% to BGN124K (expense), As Reported Other Operating Expense decrease of 45% to BGN12K (expense), Other Expenses decrease of 14% to BGN19K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


6S6 Revenue Unlock 6S6 Revenue

Net Income

6S6 Net Income Unlock 6S6 Revenue

Normalised EPS

6S6 Normalised EPS Unlock 6S6 Revenue

PE Ratio Range

6S6 PE Ratio Range Unlock 6S6 Revenue

Dividend Yield Range

6S6 Dividend Yield Range Unlock 6S6 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
6S6 EPS Forecasts Unlock 6S6 Revenue
Profile Summary

Sopharma Properties ADSITS (Sofarma Imoti ADSITS) is a Bulgaria-based real estate investment trust, licensed by the Bulgarian Financial Supervision Commission. It specializes in the securitization of real estate. The Company invests in the real estate sector by purchasing titles and other rights over land and real estate. Sofarma Imoti ADSITS Sofia acquires property rights on self-contained individual properties, multifunctional administrative, residential and commercial buildings in order to renovate, lease, rent or sell them. As of December 31, 2011, the Company’s major corporate shareholder was Telekomplekt AD with a stake of 20.50%.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated March 7, 2007
Public Since August 15, 2006
No. of Shareholders: n/a
No. of Employees: n/a
Sector Financials
Industry Residential & Commercial REITs
Exchange Bulgarian Stock Exchange
Shares in Issue 21,951,320
Free Float (0.0%)
Eligible for
6S6 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 6S6
Upcoming Events for 6S6
Frequently Asked Questions for Sopharma Properties ADSITS
What is the Sopharma Properties ADSITS share price?

As of 14/09/20, shares in Sopharma Properties ADSITS are trading at BGN5.45, giving the company a market capitalisation of £56.0m. This share price information is delayed by 15 minutes.

How has the Sopharma Properties ADSITS share price performed this year?

Shares in Sopharma Properties ADSITS are currently trading at BGN5.45 and the price has moved by -14.17% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sopharma Properties ADSITS price has moved by -5.63% over the past year.

What are the analyst and broker recommendations for Sopharma Properties ADSITS?

There are no analysts currently covering Sopharma Properties ADSITS.

When will Sopharma Properties ADSITS next release its financial results?

Sopharma Properties ADSITS is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Sopharma Properties ADSITS dividend yield?

The Sopharma Properties ADSITS dividend yield is 5.21% based on the trailing twelve month period.

Does Sopharma Properties ADSITS pay a dividend?

Last year, Sopharma Properties ADSITS paid a total dividend of 0.28, and it currently has a trailing dividend yield of 5.21%. Looking ahead, Sopharma Properties ADSITS has not announced an ex-dividend date yet.

When does Sopharma Properties ADSITS next pay dividends?

Sopharma Properties ADSITS has yet to annouce their ex-dividend date. The historic dividend yield on Sopharma Properties ADSITS shares is currently 5.21%.

How do I buy Sopharma Properties ADSITS shares?

To buy shares in Sopharma Properties ADSITS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Sopharma Properties ADSITS?

Shares in Sopharma Properties ADSITS are currently trading at BGN5.45, giving the company a market capitalisation of £56.0m.

Where are Sopharma Properties ADSITS shares listed? Where are Sopharma Properties ADSITS shares listed?

Here are the trading details for Sopharma Properties ADSITS:

Country of listing: Bulgaria
Exchange: BLG
Ticker Symbol: 6S6
What kind of share is Sopharma Properties ADSITS?

Based on an overall assessment of its quality, value and momentum, Sopharma Properties ADSITS is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Sopharma Properties ADSITS share price forecast 2020?

We were not able to load any forecast data for Sopharma Properties ADSITS.

How can I tell whether the Sopharma Properties ADSITS share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sopharma Properties ADSITS. Over the past six months, the relative strength of its shares against the market has been -20.63%. At the current price of BGN5.45, shares in Sopharma Properties ADSITS are trading at -11.37% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Sopharma Properties ADSITS PE Ratio?

The Sopharma Properties ADSITS PE ratio based on its reported earnings over the past 12 months is 15.99. The shares are currently trading at BGN5.45.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Sopharma Properties ADSITS?

Sopharma Properties ADSITS's management team is headed by:

Boris Borisov - CEO
Stefka Obreshkova - DRC
Bisera Lazarova - CHM
Petya Petkova - CAO
Who are the major shareholders of Sopharma Properties ADSITS?

Here are the top five shareholders of Sopharma Properties ADSITS based on the size of their shareholding:

Stoyev (Ventsislav Simeonov) Individual Investor
Percentage owned: 24.18% (5.31m shares)
Ivanov (Ognyan Donev) Individual Investor
Percentage owned: 22.54% (4.95m shares)
Telekomplekt Invest JSC Corporation
Percentage owned: 20.05% (4.40m shares)
Donev Investments JSC Corporation
Percentage owned: 8.78% (1.93m shares)
Similar to 6S6
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.